Standard
Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes. / Alizadeh, B Z; Hanifi-Moghaddam, P; Eerligh, P; van der Slik, A R; Kolb, H; Kharagjitsingh, A V; Pereira Arias, A M; Ronkainen, M; Knip, M; Bonfanti, R; Bonifacio, E; Prasad, Devendra; Wilkin, T; Giphart, M J; Koeleman, B P C; Nolsøe, R; Mandrup-Poulsen, Thomas; Schloot, N C; Roep, B O; DIABMARKER Study Group.
I:
Clinical and Experimental Immunology, Bind 145, Nr. 3, 01.09.2006, s. 480-4.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Alizadeh, BZ, Hanifi-Moghaddam, P, Eerligh, P, van der Slik, AR, Kolb, H, Kharagjitsingh, AV, Pereira Arias, AM, Ronkainen, M, Knip, M, Bonfanti, R, Bonifacio, E, Prasad, D, Wilkin, T, Giphart, MJ, Koeleman, BPC, Nolsøe, R
, Mandrup-Poulsen, T, Schloot, NC, Roep, BO & DIABMARKER Study Group 2006, '
Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes',
Clinical and Experimental Immunology, bind 145, nr. 3, s. 480-4.
https://doi.org/10.1111/j.1365-2249.2006.03172.xAPA
Alizadeh, B. Z., Hanifi-Moghaddam, P., Eerligh, P., van der Slik, A. R., Kolb, H., Kharagjitsingh, A. V., Pereira Arias, A. M., Ronkainen, M., Knip, M., Bonfanti, R., Bonifacio, E., Prasad, D., Wilkin, T., Giphart, M. J., Koeleman, B. P. C., Nolsøe, R.
, Mandrup-Poulsen, T., Schloot, N. C., Roep, B. O., & DIABMARKER Study Group (2006).
Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes.
Clinical and Experimental Immunology,
145(3), 480-4.
https://doi.org/10.1111/j.1365-2249.2006.03172.xVancouver
Alizadeh BZ, Hanifi-Moghaddam P, Eerligh P, van der Slik AR, Kolb H, Kharagjitsingh AV o.a.
Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes.
Clinical and Experimental Immunology. 2006 sep. 1;145(3):480-4.
https://doi.org/10.1111/j.1365-2249.2006.03172.xAuthor
Alizadeh, B Z ; Hanifi-Moghaddam, P ; Eerligh, P ; van der Slik, A R ; Kolb, H ; Kharagjitsingh, A V ; Pereira Arias, A M ; Ronkainen, M ; Knip, M ; Bonfanti, R ; Bonifacio, E ; Prasad, Devendra ; Wilkin, T ; Giphart, M J ; Koeleman, B P C ; Nolsøe, R ; Mandrup-Poulsen, Thomas ; Schloot, N C ; Roep, B O ; DIABMARKER Study Group. / Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes. I: Clinical and Experimental Immunology. 2006 ; Bind 145, Nr. 3. s. 480-4.
Bibtex
@article{b25185c31c6e43bdb820e6010a46590e,
title = "Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes",
abstract = "We studied whether serum interferon (IFN)-gamma or interleukin (IL)-10 levels and their corresponding functional polymorphic genotypes are associated with partial remission of type 1 diabetes (T1D). A multi-centre study was undertaken in patients with newly diagnosed T1D and matched controls. T1D patients were followed for 3 months and characterized for remission status. Partial clinical remission was defined as a daily insulin dose ",
keywords = "Analysis of Variance, Biological Markers, Case-Control Studies, Chi-Square Distribution, Diabetes Mellitus, Type 1, Genetic Predisposition to Disease, Genotype, Humans, Interferon-gamma, Interleukin-10, Remission, Spontaneous, Sample Size",
author = "Alizadeh, {B Z} and P Hanifi-Moghaddam and P Eerligh and {van der Slik}, {A R} and H Kolb and Kharagjitsingh, {A V} and {Pereira Arias}, {A M} and M Ronkainen and M Knip and R Bonfanti and E Bonifacio and Devendra Prasad and T Wilkin and Giphart, {M J} and Koeleman, {B P C} and R Nols{\o}e and Thomas Mandrup-Poulsen and Schloot, {N C} and Roep, {B O} and {DIABMARKER Study Group}",
year = "2006",
month = sep,
day = "1",
doi = "10.1111/j.1365-2249.2006.03172.x",
language = "English",
volume = "145",
pages = "480--4",
journal = "Clinical and Experimental Immunology, Supplement",
issn = "0964-2536",
publisher = "Wiley-Blackwell",
number = "3",
}
RIS
TY - JOUR
T1 - Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes
AU - Alizadeh, B Z
AU - Hanifi-Moghaddam, P
AU - Eerligh, P
AU - van der Slik, A R
AU - Kolb, H
AU - Kharagjitsingh, A V
AU - Pereira Arias, A M
AU - Ronkainen, M
AU - Knip, M
AU - Bonfanti, R
AU - Bonifacio, E
AU - Prasad, Devendra
AU - Wilkin, T
AU - Giphart, M J
AU - Koeleman, B P C
AU - Nolsøe, R
AU - Mandrup-Poulsen, Thomas
AU - Schloot, N C
AU - Roep, B O
AU - DIABMARKER Study Group
PY - 2006/9/1
Y1 - 2006/9/1
N2 - We studied whether serum interferon (IFN)-gamma or interleukin (IL)-10 levels and their corresponding functional polymorphic genotypes are associated with partial remission of type 1 diabetes (T1D). A multi-centre study was undertaken in patients with newly diagnosed T1D and matched controls. T1D patients were followed for 3 months and characterized for remission status. Partial clinical remission was defined as a daily insulin dose
AB - We studied whether serum interferon (IFN)-gamma or interleukin (IL)-10 levels and their corresponding functional polymorphic genotypes are associated with partial remission of type 1 diabetes (T1D). A multi-centre study was undertaken in patients with newly diagnosed T1D and matched controls. T1D patients were followed for 3 months and characterized for remission status. Partial clinical remission was defined as a daily insulin dose
KW - Analysis of Variance
KW - Biological Markers
KW - Case-Control Studies
KW - Chi-Square Distribution
KW - Diabetes Mellitus, Type 1
KW - Genetic Predisposition to Disease
KW - Genotype
KW - Humans
KW - Interferon-gamma
KW - Interleukin-10
KW - Remission, Spontaneous
KW - Sample Size
U2 - 10.1111/j.1365-2249.2006.03172.x
DO - 10.1111/j.1365-2249.2006.03172.x
M3 - Journal article
C2 - 16907917
VL - 145
SP - 480
EP - 484
JO - Clinical and Experimental Immunology, Supplement
JF - Clinical and Experimental Immunology, Supplement
SN - 0964-2536
IS - 3
ER -
